March 2026
1. CHEN Y, Wang Z, Chen H, Cui H, et al
   Plasma p-tau217 assays effectively predict amyloid status but lack precision for tau staging in Alzheimer's disease.
   J Neurol. 2026;273:183.
   

   >> Share

   
   February 2026
2. BAMFORD AR, Logan C, Do QT, Nguyen K, et al
   Salivary total tau: a clinically practical measure of tau neuropathology in Alzheimer's disease.
   J Neurol. 2026;273:149.
   

   >> Share

   
   
3. MATIAS-GUIU JA, Ortega-Madueno I, Gil-Moreno MJ, Cardenas MC, et al
   Impact of blood p-tau217 testing on diagnosis and diagnostic confidence in cognitive disorders: a real-world clinical study.
   J Neurol. 2026;273:130.
   

   >> Share

   
   
4. XIONG D, Liu M, Liu Z, Wang J, et al
   Integrating standard and native spaces for radiomics and brain network analysis in Alzheimer's disease diagnosis and prognosis.
   J Neurol. 2026;273:124.
   

   >> Share

   
   January 2026
5. CECCHINI MA, Studart-Neto A, Moraes NC, Carneiro CG, et al
   Short-term memory conjunctive binding in subjective cognitive decline: A PET biomarker-based study.
   J Neurol. 2026;273:107.
   

   >> Share

   
   
6. HAFNER F, Bernhardt A, Goldschagg N, Hopfner F, et al
   Dementia with lewy bodies and Alzheimer s Disease overlap syndrome with PSP-like phenotype caused by co-pathologies - a case report.
   J Neurol. 2026;273:62.
   

   >> Share

   
   December 2025
7. KAC PR, Gonzalez-Escalante A, Mila-Aloma M, Ashton NJ, et al
   Plasma p-tau212 identifies cognitively unimpaired individuals with emerging amyloid-beta pathology.
   J Neurol. 2025;273:48.
   

   >> Share

   
   
8. OZLU S, Dyrba M, Grazia A, Brosseron F, et al
   CSF biomarkers of neuroinflammation are associated with regional atrophy.
   J Neurol. 2025;273:46.
   

   >> Share

   
   
9. DUAN X, Wang F, Liu W, Xie Y, et al
   The diagnostic value of plasma Abeta42 and Abeta40 in Alzheimer's disease: current status, challenges, and impacting variables.
   J Neurol. 2025;273:30.
   

   >> Share

   
   
10. GUILLEN N, Esteller D, Sarto J, Perales I, et al
    Plasma p-Tau217 and GFAP predict widespread cognitive decline in Alzheimer's disease.
    J Neurol. 2025;273:28.
    

    >> Share

    
    
11. NA S, Muir K, Lophatananon A, Huang Y, et al
    Physical activity and Alzheimer's disease risk across genetic susceptibility: a prospective UK Biobank study using accelerometer data.
    J Neurol. 2025;273:1.
    

    >> Share

    
    November 2025
12. BUONOCORE J, Fratto E, Arcuri F, Vescio B, et al
    Plasma NfL and GFAP in the preclinical stages of neurodegenerative diseases: insights from the UK Biobank.
    J Neurol. 2025;272:755.
    

    >> Share

    
    
13. NOLI B, Muqaku B, Gouda M, Manai AL, et al
    VGF AQEE- and GGEE-peptides differentiate between dementia types.
    J Neurol. 2025;272:745.
    

    >> Share

    
    October 2025
14. GUO X, Yue R, Cui Z, Wang S, et al
    Advances of therapeutic strategies for Alzheimer's disease.
    J Neurol. 2025;272:705.
    

    >> Share

    
    
15. HUANG XT, Huang LY, Tan CC, Wei JM, et al
    The role of APOE epsilon4 in modulating the relationship between non-genetic risk factors and dementia: a system review and meta-analysis.
    J Neurol. 2025;272:690.
    

    >> Share

    
    
16. ELKANA O, Beheshti I
    Brain age as an accurate biomarker of preclinical cognitive decline: evidence from a 12-year longitudinal study.
    J Neurol. 2025;272:672.
    

    >> Share

    
    
17. WADOP YN, Bernal R, Njamnshi WY, Satizabal CL, et al
    Altered gut microbiota mediates the association between APOE genotype and amyloid-beta accumulation in middle-aged adults.
    J Neurol. 2025;272:670.
    

    >> Share

    
    
18. MAZZEO S, Boveri S, Bortolin E, Bruschi G, et al
    Data-driven subtypes of subjective cognitive decline: neuropsychological profiles, Alzheimer's disease biomarkers, and clinical trajectories.
    J Neurol. 2025;272:669.
    

    >> Share

    
    September 2025
19. SCHMIDT CC, Bardakan MM, Jaeger E, Richter N, et al
    Apraxic deficits predict general cognitive impairment in patients with biomarker-verified Alzheimer's pathology.
    J Neurol. 2025;272:654.
    

    >> Share

    
    
20. ALMEIDA FC, Santos A, Jesus T, Gauthreaux K, et al
    Amygdala-predominant Lewy bodies associate with cognitive decline and amygdala atrophy in Alzheimer's disease neuropathological change.
    J Neurol. 2025;272:629.
    

    >> Share

    
    August 2025
21. ZHANG Q, Lu J, Wang L, Jiao F, et al
    Evaluating (18)F-Florzolotau tau PET for Alzheimer's disease diagnosis with (18)F-Flortaucipir as reference.
    J Neurol. 2025;272:597.
    

    >> Share

    
    
22. MAZZEO S, Crucitti C, Lassi M, Ingannato A, et al
    The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer's disease.
    J Neurol. 2025;272:588.
    

    >> Share

    
    
23. DENG Z, Huang Z, Ge H, Wang H, et al
    Diagnostic performance of choroid plexus and cerebrospinal fluid space volumes in idiopathic normal pressure hydrocephalus.
    J Neurol. 2025;272:550.
    

    >> Share

    
    June 2025
24. LACZO M, Svacova Z, Lerch O, Martinkovic L, et al
    Spatial navigation deficits in early Alzheimer's disease: the role of biomarkers and APOE genotype.
    J Neurol. 2025;272:438.
    

    >> Share

    
    May 2025
25. ROSENBLOOM M, Schnee A, Nimma S, Lutz H, et al
    Monoclonal antibody administration in an academic institution and private neurological practice: a tale of two clinics.
    J Neurol. 2025;272:394.
    

    >> Share

    
    April 2025
26. MITTLER B, Cambi X, Biskach M, Reisman J, et al
    Patient journey and decision processes for anti-amyloid therapy in Alzheimer's disease.
    J Neurol. 2025;272:341.
    

    >> Share

    
    March 2025
27. KORIATH CAM, Rauchmann B, Schoeberl F, Zwergal A, et al
    Vestibular dysfunction: a hidden risk factor for Alzheimer's disease.
    J Neurol. 2025;272:285.
    

    >> Share

    
    
28. ZHANG X, Irish M, Piguet O, Ahmed RM, et al
    Behavioural and cognitive profiles in frontotemporal dementia and Alzheimer's disease: a longitudinal study.
    J Neurol. 2025;272:279.
    

    >> Share

    
    
29. JIANG Y, Jin Z, Wang H, He X, et al
    A dose-response meta-analysis of physical activity and the risk of alzheimer's disease in prospective studies.
    J Neurol. 2025;272:256.
    

    >> Share

    
    
30. ANTONIONI A, Raho EM, Di Lorenzo F, Manzoli L, et al
    Blood phosphorylated Tau217 distinguishes amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum. A systematic review and meta-analysis.
    J Neurol. 2025;272:252.
    

    >> Share

    
    
31. BUCHHOLZ E, Machule ML, Buthut M, Stefanovski L, et al
    Overlapping presence of beta-amyloid, tau, p-tau, and alpha-synuclein in skin nerve fibers in Alzheimer's disease.
    J Neurol. 2025;272:247.
    

    >> Share

    
    January 2025
32. ZAVARELLA M, Cecchetti G, Rugarli G, Ghirelli A, et al
    Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases.
    J Neurol. 2025;272:168.
    

    >> Share

    
    
33. SARTO J, Esteller-Gauxax D, Guillen N, Falgas N, et al
    Accuracy and clinical applicability of plasma tau 181 and 217 for Alzheimer's disease diagnosis in a memory clinic cohort.
    J Neurol. 2025;272:160.
    

    >> Share

    
    
34. PRASAD P, Gbadegesin O, Edwards M
    Correction: Evolving management of Alzheimer's disease.
    J Neurol. 2025;272:156.
    

    >> Share

    
    
35. ZHAO C, Li T, Hao S, Zhao L, et al
    Dysregulation of the molecular clock by blood-borne factors in Alzheimer's disease patients.
    J Neurol. 2025;272:121.
    

    >> Share

    
    December 2024
36. ZILIOLI A, Rosenberg A, Mohanty R, Matton A, et al
    Brain MRI volumetry and atrophy rating scales as predictors of amyloid status and eligibility for anti-amyloid treatment in a real-world memory clinic setting.
    J Neurol. 2024;272:84.
    

    >> Share

    
    
37. RAPOSO PEREIRA F, Chaumon M, Dubois B, Bakardjian H, et al
    Recognition memory decline is associated with the progression to prodromal Alzheimer's disease in asymptomatic at-risk individuals.
    J Neurol. 2024;272:70.
    

    >> Share

    
    
38. ERATNE D, Li QX, Lewis C, Dang C, et al
    Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort.
    J Neurol. 2024;272:25.
    

    >> Share

    
    
39. YUAN Y, Zhao G, Zhao Y
    Dysregulation of energy metabolism in Alzheimer's disease.
    J Neurol. 2024;272:2.
    

    >> Share

    
    
40. MUQAKU B, Anderl-Straub S, Werner L, Nagl M, et al
    Contactin proteins in cerebrospinal fluid show different alterations in dementias.
    J Neurol. 2024;271:7516-7524.
    

    >> Share

    
    November 2024
41. PRASAD P, Gbadegesin O, Edwards M
    Evolving management of Alzheimer's disease.
    J Neurol. 2024 Nov 9. doi: 10.1007/s00415-024-12720.
    

    >> Share

    
    September 2024
42. MITOLO M, Lombardi G, Manca R, Nacmias B, et al
    Association between blood-based protein biomarkers and brain MRI in the Alzheimer's disease continuum: a systematic review.
    J Neurol. 2024 Sep 12. doi: 10.1007/s00415-024-12674.
    

    >> Share

    
    
43. TABUAS-PEREIRA M, Bernardes C, Duraes J, Lima M, et al
    Exploring first-degree family history in a cohort of Portuguese Alzheimer's disease patients: population evidence for X-chromosome linked and recessive inheritance of risk factors.
    J Neurol. 2024 Sep 5. doi: 10.1007/s00415-024-12673.
    

    >> Share

    
    August 2024
44. CECCHETTI G, Agosta F, Rugarli G, Spinelli EG, et al
    Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer's disease: a real-world study.
    J Neurol. 2024 Aug 22. doi: 10.1007/s00415-024-12631.
    

    >> Share

    
    
45. SHAW SR, Horne KS, Piguet O, Ahmed RM, et al
    Profiles of motivational impairment and their relationship to functional decline in frontotemporal dementia.
    J Neurol. 2024;271:4963-4971.
    

    >> Share

    
    June 2024
46. FOXE D, Irish M, Carrick J, Cheung SC, et al
    Correction to: Visuospatial working memory in behavioural variant frontotemporal dementia: a comparative analysis with Alzheimer's disease using the box task.
    J Neurol. 2024 Jun 21. doi: 10.1007/s00415-024-12483.
    

    >> Share

    
    
47. LI KY, Chien CF, Huang LC, Lim K, et al
    Exploring the impact of 40 Hz multi-luminaire light exposure in Alzheimer's dementia: insights from a convenient sampling, non-randomized case-control study.
    J Neurol. 2024 Jun 17. doi: 10.1007/s00415-024-12486.
    

    >> Share

    
    May 2024
48. FOXE D, Irish M, Carrick J, Cheung SC, et al
    Visuospatial working memory in behavioural variant frontotemporal dementia: a comparative analysis with Alzheimer's disease using the box task.
    J Neurol. 2024 May 7. doi: 10.1007/s00415-024-12406.
    

    >> Share

    
    
49. CANU E, Rugarli G, Coraglia F, Basaia S, et al
    Real-word application of the AT(N) classification and disease-modifying treatment eligibility in a hospital-based cohort.
    J Neurol. 2024;271:2716-2729.
    

    >> Share

    
    April 2024
50. WANG S, Zheng X, Huang J, Liu J, et al
    Sleep characteristics and risk of Alzheimer's disease: a systematic review and meta-analysis of longitudinal studies.
    J Neurol. 2024 Apr 24. doi: 10.1007/s00415-024-12380.
    

    >> Share

    
    
51. ZAMBONI G, Maramotti R, Salemme S, Tondelli M, et al
    Age-specific prevalence of the different clinical presentations of AD and FTD in young-onset dementia.
    J Neurol. 2024 Apr 21. doi: 10.1007/s00415-024-12364.
    

    >> Share

    
    
52. GUILOFF AE, Rudge P
    Amyloid antibody therapy for early-stage Alzheimer's disease: a critical review of three recent trials.
    J Neurol. 2024 Apr 13. doi: 10.1007/s00415-024-12361.
    

    >> Share

    
    
53. LAVROVA A, Pham NTT, Vernon CJ, Carlos AF, et al
    A multimodal clinical diagnostic approach using MRI and (18)F-FDG-PET for antemortem diagnosis of TDP-43 in cases with low-intermediate Alzheimer's disease neuropathologic changes and primary age-related tauopathy.
    J Neurol. 2024 Apr 5. doi: 10.1007/s00415-024-12312.
    

    >> Share

    
    
54. MENDES AJ, Ribaldi F, Lathuiliere A, Ashton NJ, et al
    Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort.
    J Neurol. 2024;271:2053-2066.
    

    >> Share

    
    
55. O'CONNOR A, Lyons S, Finnegan M, Walsh J, et al
    Expanding the phenotype of psychiatric-onset prodromal dementia with Lewy bodies.
    J Neurol. 2024;271:2125-2128.
    

    >> Share

    
    
56. SARTO J, Esteller-Gauxax D, Tort-Merino A, Guillen N, et al
    Impact of demographics and comorbid conditions on plasma biomarkers concentrations and their diagnostic accuracy in a memory clinic cohort.
    J Neurol. 2024;271:1973-1984.
    

    >> Share

    
    March 2024
57. LANGERSCHEIDT F, Wied T, Al Kabbani MA, van Eimeren T, et al
    Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies.
    J Neurol. 2024 Mar 30. doi: 10.1007/s00415-024-12314.
    

    >> Share

    
    
58. SINGH NA, Graff-Radford J, Machulda MM, Carlos AF, et al
    Atypical Alzheimer's disease: new insights into an overlapping spectrum between the language and visual variants.
    J Neurol. 2024 Mar 29. doi: 10.1007/s00415-024-12297.
    

    >> Share

    
    
59. PENG M, Yuan S, Lu D, Ling Y, et al
    Dietary inflammatory index, genetic susceptibility and risk of incident dementia: a prospective cohort study from UK biobank.
    J Neurol. 2024;271:1286-1296.
    

    >> Share

    
    February 2024
60. SUBOTIC A, Gee M, Nelles K, Ba F, et al
    Gray matter loss relates to dual task gait in Lewy body disorders and aging.
    J Neurol. 2024;271:962-975.
    

    >> Share

    
    January 2024
61. HUANG M, Landin-Romero R, Matis S, Dalton MA, et al
    Longitudinal volumetric changes in amygdala subregions in frontotemporal dementia.
    J Neurol. 2024 Jan 24. doi: 10.1007/s00415-023-12172.
    

    >> Share

    
    
62. GENG C, Meng K, Tang Y
    Identifying the mediating role of inflammation on the relationship between socioeconomic status and Alzheimer's disease: a Mendelian randomization analysis and mediation analysis.
    J Neurol. 2024 Jan 22. doi: 10.1007/s00415-023-12176.
    

    >> Share

    
    
63. HENNEY AE, Gillespie CS, Alam U, Hydes TJ, et al
    High intake of ultra-processed food is associated with dementia in adults: a systematic review and meta-analysis of observational studies.
    J Neurol. 2024;271:198-210.
    

    >> Share

    
    December 2023
64. MASSA F, Martinuzzo C, Gomez de San Jose N, Pelagotti V, et al
    Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease.
    J Neurol. 2023 Dec 29. doi: 10.1007/s00415-023-12154.
    

    >> Share

    
    
65. RONAT L, Hanganu A, Chylinski D, Van Egroo M, et al
    Prediction of cognitive decline in healthy aging based on neuropsychiatric symptoms and PET-biomarkers of Alzheimer's disease.
    J Neurol. 2023 Dec 19. doi: 10.1007/s00415-023-12131.
    

    >> Share

    
    November 2023
66. ST-GEORGES MA, Wang L, Chapleau M, Migliaccio R, et al
    Social cognition and behavioral changes in patients with posterior cortical atrophy.
    J Neurol. 2023 Nov 30. doi: 10.1007/s00415-023-12089.
    

    >> Share

    
    
67. PEREZ-MILLAN A, Borrego-Ecija S, Falgas N, Junca-Parella J, et al
    Cortical thickness modeling and variability in Alzheimer's disease and frontotemporal dementia.
    J Neurol. 2023 Nov 27. doi: 10.1007/s00415-023-12087.
    

    >> Share

    
    
68. VRILLON A, Ashton NJ, Karikari TK, Gotze K, et al
    Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study.
    J Neurol. 2023 Nov 11. doi: 10.1007/s00415-023-12066.
    

    >> Share

    
    September 2023
69. STAM D, Rosseel S, De Winter FL, Van den Bossche MJA, et al
    Facial expression recognition deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic investigation of effects of phenotypic variant, task modality, geographical region and symptomatic specificity.
    J Neurol. 2023 Sep 6. doi: 10.1007/s00415-023-11927.
    

    >> Share

    
    
70. CHAN E, Bonifacio GB, Harrison C, Banerjee G, et al
    Domain-specific neuropsychological investigation of CAA with and without intracerebral haemorrhage.
    J Neurol. 2023 Sep 6. doi: 10.1007/s00415-023-11977.
    

    >> Share

    
    
71. DAMSGAARD L, Janbek J, Laursen TM, Waldemar G, et al
    Healthcare utilization prior to a diagnosis of young-onset Alzheimer's disease: a nationwide nested case-control study.
    J Neurol. 2023 Sep 5. doi: 10.1007/s00415-023-11974.
    

    >> Share

    
    July 2023
72. PENA-BAUTISTA C, Alvarez-Sanchez L, Ferrer-Cairols I, Garcia-Valles L, et al
    Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression.
    J Neurol. 2023 Jul 28. doi: 10.1007/s00415-023-11899.
    

    >> Share

    
    
73. MIZUTANI Y, Ohdake R, Tatebe H, Higashi A, et al
    Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease.
    J Neurol. 2023 Jul 22. doi: 10.1007/s00415-023-11875.
    

    >> Share

    
    
74. SAW AM, Hrastelj J, Robertson NP
    Path from discovery to recovery: therapeutic and diagnostic advances in Alzheimer's dementia.
    J Neurol. 2023 Jul 3. doi: 10.1007/s00415-023-11840.
    

    >> Share

    
    June 2023
75. KUCIKOVA L, Zeng J, Munoz-Neira C, Muniz-Terrera G, et al
    Genetic risk factors of Alzheimer's Disease disrupt resting-state functional connectivity in cognitively intact young individuals.
    J Neurol. 2023 Jun 26. doi: 10.1007/s00415-023-11809.
    

    >> Share

    
    April 2023
76. LING Y, Yuan S, Huang X, Tan S, et al
    The association of night shift work with the risk of all-cause dementia and Alzheimer's disease: a longitudinal study of 245,570 UK Biobank participants.
    J Neurol. 2023 Apr 6. doi: 10.1007/s00415-023-11672.
    

    >> Share

    
    
77. FERRUCCI R, Cuffaro L, Capozza A, Rosci C, et al
    Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19.
    J Neurol. 2023;270:1823-1834.
    

    >> Share

    
    
78. TAYLOR NL, Shine JM
    A whole new world: embracing the systems-level to understand the indirect impact of pathology in neurodegenerative disorders.
    J Neurol. 2023;270:1969-1975.
    

    >> Share

    
    
79. CONSTANTINIDES VC, Tentolouris-Piperas V, Paraskevas GP, Pyrgelis ES, et al
    Hippocampal subfield volumetry in corticobasal syndrome of diverse underlying pathologies.
    J Neurol. 2023;270:2059-2068.
    

    >> Share

    
    March 2023
80. SEMENKOVA A, Piguet O, Johnen A, Schroeter ML, et al
    The Behavioural Dysfunction Questionnaire discriminates behavioural variant frontotemporal dementia from Alzheimer's disease dementia and major depressive disorder.
    J Neurol. 2023 Mar 23. doi: 10.1007/s00415-023-11666.
    

    >> Share

    
    
81. FILIPPI M, Cecchetti G, Cagnin A, Marra C, et al
    Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer's disease: an expert opinion and practical guideline.
    J Neurol. 2023 Mar 9. doi: 10.1007/s00415-023-11642.
    

    >> Share

    
    February 2023
82. JISKOOT LC, Russell LL, Greaves CV, van Schaik E, et al
    Addition of the FTD Module to the Neuropsychiatric Inventory improves classification of frontotemporal dementia spectrum disorders.
    J Neurol. 2023 Feb 22. doi: 10.1007/s00415-023-11596.
    

    >> Share

    
    January 2023
83. CRETIN B, Philippi N, Bousiges O, Blanc F, et al
    Transient epileptic amnesia: a retrospective cohort study of 127 cases, including CSF amyloid and tau features.
    J Neurol. 2023 Jan 30. doi: 10.1007/s00415-023-11576.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share